Invention Grant
- Patent Title: Use of icaritin in preparing medicament for preventing or treating hematocytopenia
-
Application No.: US15030671Application Date: 2014-10-20
-
Publication No.: US10555962B2Publication Date: 2020-02-11
- Inventor: Zhiquan Zhao , Jingchun Yao , Xin Li , Yongxia Guan , Guangyan Li
- Applicant: Lunan Pharmaceutical Group Corporation
- Applicant Address: CN Linyi
- Assignee: Lunan Pharmaceutical Group Corporation
- Current Assignee: Lunan Pharmaceutical Group Corporation
- Current Assignee Address: CN Linyi
- Agency: Renner, Otto, Boisselle & Sklar LLP
- Priority: CN201310493718 20131021; CN201310646101 20131204
- International Application: PCT/CN2014/088944 WO 20141020
- International Announcement: WO2015/058664 WO 20150430
- Main IPC: A61K31/7048
- IPC: A61K31/7048 ; A61K9/00 ; A61K9/107 ; A61K9/16 ; A61K9/20 ; A61K9/48 ; A61K45/06
Abstract:
The present application relates to use of icaritin in preparing a medicament for preventing or treating hematocytopenia. Particularly, icaritin may be used to prevent or treat bone marrow suppression caused by chemotherapeutic drugs, and may also be used to prevent or treat thrombocytopenia, for example, immune thrombocytopenia.
Public/Granted literature
- US20160250243A1 USE OF ICARITIN IN PREPARING MEDICAMENT FOR PREVENTING OR TREATING HEMATOCYTOPENIA Public/Granted day:2016-09-01
Information query
